Junjie Hu

1.5k total citations · 1 hit paper
56 papers, 815 citations indexed

About

Junjie Hu is a scholar working on Molecular Biology, Epidemiology and Cancer Research. According to data from OpenAlex, Junjie Hu has authored 56 papers receiving a total of 815 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 13 papers in Epidemiology and 12 papers in Cancer Research. Recurrent topics in Junjie Hu's work include Liver Disease Diagnosis and Treatment (12 papers), Cancer, Lipids, and Metabolism (7 papers) and Drug Transport and Resistance Mechanisms (6 papers). Junjie Hu is often cited by papers focused on Liver Disease Diagnosis and Treatment (12 papers), Cancer, Lipids, and Metabolism (7 papers) and Drug Transport and Resistance Mechanisms (6 papers). Junjie Hu collaborates with scholars based in China, United States and Germany. Junjie Hu's co-authors include Zhenpeng Qiu, Cong Zhang, Xin Chen, Guohua Zheng, Guohua Zheng, Ming Yuan, Diego F. Calvisi, Li Che, Lei Sheng and Silvia Ribback and has published in prestigious journals such as Cancer Research, Journal of Agricultural and Food Chemistry and Scientific Reports.

In The Last Decade

Junjie Hu

50 papers receiving 802 citations

Hit Papers

Histone lactylation-drive... 2025 2026 2025 5 10 15 20 25

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junjie Hu China 17 420 234 140 98 87 56 815
Ruidong Li China 20 618 1.5× 183 0.8× 144 1.0× 181 1.8× 64 0.7× 32 1.1k
Julio Isael Pérez‐Carreón Mexico 17 468 1.1× 141 0.6× 97 0.7× 73 0.7× 57 0.7× 47 772
Maria Grazia Refolo Italy 18 459 1.1× 246 1.1× 146 1.0× 223 2.3× 175 2.0× 30 992
Sam Seok Cho South Korea 17 373 0.9× 147 0.6× 257 1.8× 49 0.5× 148 1.7× 27 794
Feng Ren China 19 721 1.7× 437 1.9× 166 1.2× 73 0.7× 53 0.6× 24 1.1k
Isabel Moreira da Silva Portugal 9 281 0.7× 158 0.7× 189 1.4× 103 1.1× 42 0.5× 22 602
Praveen Kusumanchi United States 16 384 0.9× 202 0.9× 280 2.0× 76 0.8× 86 1.0× 34 822
Xuanfu Xu China 14 470 1.1× 243 1.0× 159 1.1× 186 1.9× 63 0.7× 25 820
Jaime Arellanes‐Robledo Mexico 18 361 0.9× 92 0.4× 234 1.7× 52 0.5× 139 1.6× 52 822
Wenwen Wang China 17 329 0.8× 82 0.4× 214 1.5× 154 1.6× 128 1.5× 32 932

Countries citing papers authored by Junjie Hu

Since Specialization
Citations

This map shows the geographic impact of Junjie Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junjie Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junjie Hu more than expected).

Fields of papers citing papers by Junjie Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junjie Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junjie Hu. The network helps show where Junjie Hu may publish in the future.

Co-authorship network of co-authors of Junjie Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Junjie Hu. A scholar is included among the top collaborators of Junjie Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junjie Hu. Junjie Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Jianming, Wenlong Jia, Le Li, et al.. (2025). Histone lactylation-driven B7-H3 expression promotes tumor immune evasion. Theranostics. 15(6). 2338–2359. 26 indexed citations breakdown →
3.
Tang, Jun, Ziwei Gao, Yan Meng, et al.. (2025). Construction of dual-targeted liposomes loaded with celastrol and their application in treating intrahepatic cholangiocarcinoma. Materials Today Bio. 31. 101581–101581.
5.
Hu, Junjie, Chengqi Zhang, Hao Xu, et al.. (2025). pH-Responsive Nanosuspension Based on an Orthoester for Synergistic Chemodynamic and Photothermal Therapy in Localized Cancer Treatment. ACS Applied Bio Materials. 8(7). 5854–5868.
6.
Wang, Qi, Xin Chen, Yan Meng, et al.. (2025). Hu-lu-su-pian ameliorates hepatic steatosis by regulating CIDEA expression in AKT-driven MASLD mice. Frontiers in Pharmacology. 15. 1503247–1503247. 3 indexed citations
7.
Hu, Yinchun, et al.. (2024). Water-triggered shape memory cellulose / sodium alginate / montmorillonite composite sponges for rapid hemostasis. International Journal of Biological Macromolecules. 271(Pt 2). 132679–132679. 6 indexed citations
9.
Huang, Siying, et al.. (2024). Development of Dual-Targeted Mixed Micelles Loaded with Celastrol and Evaluation on Triple-Negative Breast Cancer Therapy. Pharmaceutics. 16(9). 1174–1174. 4 indexed citations
10.
Liu, Xuanyu, et al.. (2024). Self-gelling, tunable adhesion, antibacterial and biocompatible quaternized cellulose/tannic acid/polyethylene glycol/montmorillonite composite powder for quick hemostasis. International Journal of Biological Macromolecules. 282(Pt 1). 136646–136646. 7 indexed citations
12.
Huang, Xinyu, et al.. (2023). The essential effect of mTORC1-dependent lipophagy in non-alcoholic fatty liver disease. Frontiers in Pharmacology. 14. 1124003–1124003. 6 indexed citations
13.
Chen, Xin, Lei Sheng, Qi Wang, et al.. (2022). Metabolomics profiling of AKT/c-Met-induced hepatocellular carcinogenesis and the inhibitory effect of Cucurbitacin B in mice. Frontiers in Pharmacology. 13. 1009767–1009767. 6 indexed citations
14.
Xu, Yongjin, Haifeng Chen, Junjie Hu, et al.. (2022). Advances of targeting the YAP/TAZ-TEAD complex in the hippo pathway for the treatment of cancers. European Journal of Medicinal Chemistry. 244. 114847–114847. 24 indexed citations
15.
Li, Dan, Tao Yu, Junjie Hu, et al.. (2021). Downregulation of CYP39A1 Serves as a Novel Biomarker in Hepatocellular Carcinoma with Worse Clinical Outcome. Oxidative Medicine and Cellular Longevity. 2021(1). 5175581–5175581. 10 indexed citations
16.
Chen, Xinyan, et al.. (2020). Celastrol-Loaded Galactosylated Liposomes Effectively Inhibit AKT/c-Met-Triggered Rapid Hepatocarcinogenesis in Mice. Molecular Pharmaceutics. 17(3). 738–747. 43 indexed citations
17.
Liu, Xianqiong, Junjie Hu, Xinhua Song, et al.. (2019). Combined Treatment with MEK and mTOR Inhibitors is Effective in In Vitro and In Vivo Models of Hepatocellular Carcinoma. Cancers. 11(7). 930–930. 11 indexed citations
18.
Yu, Jialing, et al.. (2019). [Single nucleotide polymorphism microarray in prenatal diagnosis of fetuses with absent nasal bone].. PubMed. 48(4). 414–419. 1 indexed citations
19.
Méndez‐Lucas, Andrés, Xiaolei Li, Junjie Hu, et al.. (2017). Glucose Catabolism in Liver Tumors Induced by c-MYC Can Be Sustained by Various PKM1/PKM2 Ratios and Pyruvate Kinase Activities. Cancer Research. 77(16). 4355–4364. 67 indexed citations
20.
Lin, Rong, Yunxia Zhang, Dongjing Yan, et al.. (2015). Association of common variants in TOMM40/APOE/APOC1 region with human longevity in a Chinese population. Journal of Human Genetics. 61(4). 323–328. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026